[13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity.

OBJECTIVES A major side effect of antiretroviral drugs is nucleoside reverse transcriptase inhibitor (NRTI)-related mitochondrial toxicity, the in vivo diagnosis of which is difficult and not yet standardized. We used the [(13)C]methionine breath test to investigate hepatic mitochondrial oxidation in HIV-1-infected patients receiving antiretroviral therapy. PATIENTS AND METHODS The [(13)C]methionine breath test was performed in healthy subjects (n=10), HIV-infected patients on antiretroviral therapy with (n=6) and without (n=15) hyperlactataemia and naive HIV-infected patients (n=11). After oral administration of [(13)C]methionine (2 mg/kg body weight), hepatic methionine metabolism was measured by breath (13)CO(2) enrichment, expressed as delta over baseline (DOB) every 15 min for 120 min by mass spectrometry. RESULTS The four study groups showed a significant difference in (13)CO(2) exhalation (P=0.001). HIV-infected patients on antiretroviral therapy with normal serum lactate had reduced exhalation of (13)CO(2) compared with healthy subjects (DOB mean peak: 8.82+/-0.62 versus 11+/-0.9, P<0.05). HIV patients with hyperlactataemia had even lower values when compared with patients with normal lactataemia (DOB mean peak: 4.98+/-0.68 versus 8.82+/-0.62, P<0.05). CONCLUSIONS The [(13)C]methionine breath test possibly showed mitochondrial impairment in antiretroviral-treated HIV-positive patients, particularly with hyperlactataemia. This non-invasive test can be used to monitor drug-related mitochondrial toxicity in vivo and to discover early and asymptomatic damage of the respiratory chain.

[1]  M. Stipanuk Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. , 2004, Annual review of nutrition.

[2]  M. Moroni,et al.  13C-Methionine breath test detects liver mitochondrial impairment in HIV-infected patients with antiretroviral drug-related hyperlactatemia. , 2004, Journal of acquired immune deficiency syndromes.

[3]  R. Naviaux,et al.  Quantitation of Blood Lymphocyte Mitochondrial DNA for the Monitoring of Antiretroviral Drug‐Induced Mitochondrial DNA Depletion , 2003, Journal of acquired immune deficiency syndromes.

[4]  A. Diehl,et al.  Hyperlactataemia syndromes associated with HIV therapy. , 2003, The Lancet. Infectious diseases.

[5]  W. Lewis Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions. , 2003, Antiviral research.

[6]  F. Negro,et al.  Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[7]  R. Hogg,et al.  Random venous lactate levels among HIV-positive patients on antiretroviral therapy. , 2002, Journal of acquired immune deficiency syndromes.

[8]  C. Mussini,et al.  Increased Mitochondrial Dna Content in Peripheral Blood Lymphocytes from HIV-Infected Patients with Lipodystrophy , 2002, Antiviral therapy.

[9]  P. Harrigan,et al.  Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. , 2002, The New England journal of medicine.

[10]  M. Lederman,et al.  Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy , 2002, AIDS.

[11]  P. Brambilla,et al.  Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy. , 2002, The Journal of infectious diseases.

[12]  L. Rubbia‐Brandt,et al.  CASE REPORT: Acute Valproate-Associated Microvesicular Steatosis: Could the [13C]Methionine Breath Test Be Useful to Assess Liver Mitochondrial Function? , 2001, Digestive Diseases and Sciences.

[13]  A. Telenti,et al.  Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  K. Anderson,et al.  Toxicity of Antiviral Nucleoside Analogs and the Human Mitochondrial DNA Polymerase* , 2001, The Journal of Biological Chemistry.

[15]  C. Moore,et al.  Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy , 2001, AIDS.

[16]  K. Brinkman Management of hyperlactatemia: no need for routine lactate measurements. , 2001, AIDS.

[17]  V. Darley-Usmar,et al.  Differential Effects of Antiretroviral Nucleoside Analogs on Mitochondrial Function in HepG2 Cells , 2000, Antimicrobial Agents and Chemotherapy.

[18]  A. Gasbarrini,et al.  Non-Invasive Assessment of Human Hepatic Mitochondrial Function through the 13C-Methionine Breath Test , 2000, Scandinavian journal of gastroenterology.

[19]  C. H. Chen,et al.  Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. , 1991, Molecular pharmacology.

[20]  J. Finkelstein,et al.  Methionine metabolism in mammals. , 1990, The Journal of nutritional biochemistry.

[21]  Arthur J. L. Cooper Methionine transamination in vivo. , 1989, The Biochemical journal.

[22]  E. White,et al.  Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases. , 1989, Biochemical and biophysical research communications.

[23]  C. Scriver,et al.  Labile methyl group balances in the human: the role of sarcosine. , 1980, Metabolism: clinical and experimental.

[24]  N. Benevenga,et al.  Identification of 3-methylthiopropionic acid as an intermediate in mammalian methionine metabolism in vitro. , 1978, The Journal of biological chemistry.

[25]  S. Mudd,et al.  Labile methyl balances for normal humans on various dietary regimens. , 1975, Metabolism: clinical and experimental.

[26]  C. Mackenzie,et al.  Coupled flavoenzymes in mitochondrial oxidation of N-methyl groups. , 1962, The Journal of biological chemistry.

[27]  A. Gasbarrini,et al.  13C-breath tests in the study of mitochondrial liver function. , 2004, European review for medical and pharmacological sciences.

[28]  M. Pajares,et al.  S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. , 1997, Pharmacology & therapeutics.

[29]  J. R. Thompson,et al.  Is methionine transaminated in skeletal muscle? , 1989, The Biochemical journal.

[30]  M. Stipanuk Metabolism of sulfur-containing amino acids. , 1986, Annual review of nutrition.